Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial

Những quyển sách tương tự

• Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis
  Bằng: Hirashima, Tomonori, et al.
  Được phát hành: (2019)
• Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples
  Bằng: Kiura, Katsuyuki, et al.
  Được phát hành: (2018)
• Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset
  Bằng: Ohe, Yuichiro, et al.
  Được phát hành: (2018)
• Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy
  Bằng: Tokudome, Nahomi, et al.
  Được phát hành: (2020)
• Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
  Bằng: Sakai, Kazuko, et al.
  Được phát hành: (2020)